Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 29,2025 No.2 Detail

Study on UPLC fingerprint of Shangke Dieda tablets and determination of ten components

Published on Mar. 12, 2025Total Views: 264 times Total Downloads: 50 times Download Mobile

Author: TIAN Jinmiao ZHANG Xu ZHOU Nan TANG Xueting KONG Lingfeng ZHOU Chunling

Affiliation: Liaoning Inspection, Examination & Certification Centre, Liaoning Institute for Drug Control, Shenyang 110036, China

Keywords: Shangke Dieda tablets Fingerprint Determination Ultra performance liquid chromatography Paeoniae radix Aucklandiae radix Aurantii fructus and Citri reticulatae pericarpium viride Rhei radix et rhizoma

DOI: 10.12173/j.issn.2097-4922.202409066

Reference: TIAN Jinmiao, ZHANG Xu, ZHOU Nan, TANG Xueting, KONG Lingfeng, ZHOU  Chunling. Study on UPLC fingerprint of Shangke Dieda tablets and determination of ten components[J]. Yaoxue QianYan Zazhi, 2025, 29(2): 218-226. DOI: 10.12173/j.issn.2097-4922.202409066.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To establish an ultra-high performance liquid chromatography (UPLC) fingerprint for Shangke Dieda tablets, in order to better control product quality, and to determine the contents of 10 components including paeoniflorin, naringin, hesperidin, neohesperidin, lignan lactone, dehydrolignan lactone, aloe emodin, rhein, emodin, and emodin methyl ether simultaneously.

Methods  The chromatographic separation was performed on a Agilent InfinityLab Poroshell 120 SB-C18 column (100 mm×4.6 mm, 2.7 μm). Acetonitrile-0.1% phosphoric acid aqueous solution was used as mobile phase for gradient elution, the flow rate was 1.0 mL/min, the column temperature was 30 ℃, the detection wavelength was 230 nm and the sample amount was 5 µL. The UPLC fingerprints of Shangke Dieda tablets were established, the similarity of 74 batches of Shangke Dieda tablets from 10 production enterprises were evaluated using traditional Chinese medicine chromatographic fingerprint similarity evaluation software, and the content of 10 components in Shangke Dieda tablets were determined.

Results  The results showed that a total of 10 common peaks were identified in the UPLC fingerprint of Shangke Dieda tablets, and the similarity of 74 batches of Shangke Dieda tablets were at the range of 0.85 to 0.99. The linear relationships of paeoniflorin, naringin, hesperidin, neohesperidin, lignan lactone, dehydrolignan lactone, aloe emodin, rhein, emodin, and emodin methyl ether were good, with r≥ 0.999  8. The average recovery rate was in the range of 97.0% to 105.1%, with RSD of 0.4% to 2.0% (n=6). The contents of these 10 components in 74 batches of Shangke Dieda tablets were as follows: 0.028-0.653, 0.042-0.931, 0.591-3.978, 0.021-0.593, 0-0.157, 0.009-0.231, 0.006-0.078, 0.022-0.593, 0.029-0.143 and 0.035-0.132 mg/tablet.

Conclusion   The UPLC fingerprint for Shangke Dieda tablets was established successfully, which can provide a basis for the quality evaluation of Shangke Dieda tablets. The method of simultaneously determining the content of 10 components is easy to operate and the results are accurate and reliable.

Full-text
Please download the PDF version to read the full text: download
References

1.文秀云. 伤科跌打片薄层色谱鉴别研究[J]. 医学信息(中旬刊), 2011, 24(8): 3775-3776. [Wen XY. Study on thin layer chromatography identification of Shangke Dieda tablets[J]. Medical Information, 2011, 24(8): 3775-3776.] DOI: 10.3969/j.issn.1006-1959.2011.08.301.

2.姜春霞, 单淑敏, 张丽萍. HPLC法测定伤科跌打片中大黄素大黄酚的含量[J]. 辽宁中医杂志, 2005, 32(11): 1194. [Jiang CX, Shan SM, Zhang LP. Determination of emodin and emodin in Shangke Dieda tablets by HPLC[J]. Liaoning Journal of Traditional Chinese Medicine, 2005, 32(11): 1194.] DOI: 10.3969/j.issn.1000-1719.2005.11.073.

3.卢敏, 刘向前, 姚晓勃, 等. 伤科跌打片治疗创伤性软组织肿痛385例疗效观察[J]. 当代医师杂志, 1998, 3(4): 48. [Lu  M, Liu XQ, Yao XB, et al. Observation of the therapeutic effect of Shangke Dieda tablets on 385 cases of traumatic soft tissue swelling and pain[J]. Journal of Chinese Physician, 1998, 3(4): 48.] https://www.cqvip.com/QK/98563X/199804/2944309.html.

4.陈学艳, 魏文芝, 张敏娟, 等. UHPLC法同时测定复方龙胆碳酸氢钠片中10种大黄蒽醌类成分及土大黄苷的含量[J]. 中国药房, 2023, 34(21): 2595-2600. [Chen XY, Wei WZ, Zhang MJ, et al. Simultaneous determination of 10 rhubarb anthraquinones and rhaponticin in Compound gentian and sodium bicarbonate tablets by UPLC[J]. China Pharmacy, 2023, 34(21): 2595-2600.] DOI: 10.6039/j.issn.1001-0408.2023.21.05.

5.熊良益, 高永坚, 林碧珊, 等. 经典名方养胃汤基准样品UHPLC指纹图谱及含量测定研究[J]. 中草药, 2024, 55(3): 798-810. [Xiong LY, Gao YJ, Lin BS, et al. UPLC fingerprint and content determination of classic prescription Yangwei decoction benchmark sample[J]. Chinese Traditional and Herbal Drugs, 2024, 55(3): 798-810.] DOI: 10.7501/j.issn.0253-2670.2024.03.011.

6.任慧, 郭盛, 许小雪, 等. 补肺活血胶囊UHPLC指纹图谱建立及质量评价[J]. 中国现代中药, 2022, 24(11): 2214-2221. [Ren H, Guo S, Xu XX, et al. UPLC Fingerprint establishment and quality evaluation of Bufei Huoxue capsule[J]. Modern Chinese Medicine, 2022, 24(11): 2214-2221.] DOI: 10.13313/j.issn.1673-4890.20220329002.

7.王影, 秦玉华, 朱莉莉, 等. 伤科跌打片提取工艺试验研究[J]. 亚太传统医药, 2013, 9(11): 30-31. [Wang Y, Qin YH, Zhu LL, et al. Experimental study on extraction process of traumatic bone injury tablets[J]. Asia-Pacific Traditional Medicine, 2013, 9(11): 30-31.] DOI: CNKI:SUN:YTCT.0.2013-11-014.

8.樊省安, 马越, 李妍怡. 伤科跌打片治疗感冒1例[J]. 内蒙古中医药, 2014, 33(30): 128. [Fan SA, Ma Y, Li YY. One case of treating a cold with Shangke Dieda tablets[J]. Inner Mongolia Journal of Traditional Chinese, 2014, 33(30): 128.] DOI: 10.16040/j.cnki.cn15-1101.2014.30.140.

9.昝丹娅. 超高效液相色谱法在药物分析中的应用进展[J]. 临床医药文献电子杂志, 2019, 6(30): 189-190. [Zan DY. Progress in the application of ultra high performance liquid chromatography in pharmaceutical analysis[J]. Electronic Journal of Clinical Medical Literature, 2019, 6(30): 189-190.] DOI: CNKI:SUN:LCWX.0.2019-30-167.

10.李沁, 张聪, 陈亮, 等. 基于超高效液相色谱指纹图谱、多指标成分定量及化学计量学的小儿感冒颗粒质量评价[J]. 药物分析杂志, 2023, 43(9): 1612-1622. [Li Q, Zhang C, Chen L, et al. Quality evaluation of Xiao'er Ganmao granules based on UPLC fingerprint, multi-component determination, and chemometric analysis[J]. Chinese Journal of Pharmaceutical Analysis, 2023, 43(9): 1612-1622.] DOI: 10.16155/j.0254-1793.2023.09.19.

Popular papers
Last 6 months